Guoxiong Luo
-
- MicroRNA in disease regulation 2
-
- RNA Interference and Gene Delivery 2
- Advanced biosensing and bioanalysis techniques 2
- Circular RNAs in diseases 2
- Clinical Biochemistry top 10%
-
- Renal cell carcinoma treatment 2
-
- Inflammatory Biomarkers in Disease Prognosis 2
-
- Radiomics and Machine Learning in Medical Imaging 1
-
- Stress Responses and Cortisol 1
- Co-authors
- Kesheng ZhaoHazel H. SzetoSerena GiannelliPeter W. SchillerGuomin ZhaoLichuan YangM. Flint BealNoel Y. Calingasan
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Guoxiong Luo
13 papers receiving 784 citations
Peers
Comparison fields: 5 of 91
- Cancer Research 122
- Molecular Biology 479
- Clinical Biochemistry 40
- Physiology 142
- Developmental Neuroscience 19
Countries citing papers authored by Guoxiong Luo
This map shows the geographic impact of Guoxiong Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guoxiong Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guoxiong Luo more than expected).
Fields of papers citing papers by Guoxiong Luo
This network shows the impact of papers produced by Guoxiong Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guoxiong Luo. The network helps show where Guoxiong Luo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Guoxiong Luo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 2 | |
| 3 | 2017 | 53 | |
| 4 | 2016 | 31 | |
| 5 | 2016 | 60 | |
| 6 | 2016 | 37 | |
| 7 | [Overexpression of SEPP1 inhibits the proliferation and induces cell cycle G2/M arrest of 786-O and 769-P human renal carcinoma cells]. | 2016 | 3 |
| 8 | 2013 | 4 | |
| 9 | 2009 | 144 | |
| 10 | 2005 | 215 | |
| 11 | 2004 | 84 | |
| 12 | 2003 | 126 | |
| 13 | 2002 | 33 |
About Guoxiong Luo
Guoxiong Luo is a scholar working on Behavioral Neuroscience, Cancer Research and Geriatrics and Gerontology, having authored 13 papers that have together received 793 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (2 papers), RNA Interference and Gene Delivery (2 papers), MicroRNA in disease regulation (2 papers), Advanced biosensing and bioanalysis techniques (2 papers), Inflammatory Biomarkers in Disease Prognosis (2 papers), Circular RNAs in diseases (2 papers), Radiomics and Machine Learning in Medical Imaging (1 paper) and Stress Responses and Cortisol (1 paper). The work is most often cited by research in Cancer Research (122 citations), Molecular Biology (479 citations) and Clinical Biochemistry (40 citations). Guoxiong Luo has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Kesheng Zhao, Hazel H. Szeto, Serena Giannelli, Peter W. Schiller, Guomin Zhao, Lichuan Yang, M. Flint Beal, Noel Y. Calingasan, Xu Zhang and Liangyou Gu. Their work appears in journals such as PLoS ONE, Scientific Reports and The FASEB Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.